Li Z L, Chen J L, Tang Y, Qin D L, Chen C, Qiu Y H, Wu H, He Y, Mao X H, Zhai W L, Li J D, Liang X, Sun C D, Ma K, Geng Z M, Tang Z H, Quan Z W
Department of General Surgery,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China.
Department of Hepatobiliary Surgery,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China.
Zhonghua Wai Ke Za Zhi. 2024 Jul 1;62(7):685-696. doi: 10.3760/cma.j.cn112139-20231215-00275.
To investigate the effect of the number of positive preoperative serological tumor markers on the surgical approach and prognosis of patients with intrahepatic cholangiocarcinoma. This is a retrospective case-series study. Data from 548 patients with intrahepatic cholangiocarcinoma after radical resection from October 2010 to April 2019 were retrospectively collected in 10 hospitals of China. There were 277 males and 271 females with an age of (57.8±10.2)years(range:23 to 84 years). Four hundred and twenty-six patients(77.7%) had at least one positive preoperative serum tumor marker. The data collection included the results of 4 preoperative serological tumor markers,other preoperative indicators(5 prodromal symptoms, 6 medical history,8 preoperative serological indicators,5 preoperative imaging indicators,and 14 preoperative pathological examination indicators),baseline data (gender and age),surgical methods,and prognostic follow-up data. Four preoperative results of serologic tumor marker and surgical procedure were converted into categorical variables. The number of positive preoperative serum tumor markers was used as the treatment variable,the surgical method was used as the mediating variable,and the survival time was used as the outcome variable. Univariate and multivariate analysis were used to screen for other preoperative indicators which were independent factors that influenced the surgical procedure and the prognosis of patients as covariates to analyze the mediating effect. Of the 548 patients included in the study, 176 patients (32.1%) underwent partial hepatectomy,151 patients(27.5%) underwent hemihepatectomy, and 221 patients(40.3%) underwent partial hepatectomy or hemihepatectomy combined with other treatments. The results of the univariate and multivariate analysis showed that the number of positive serum tumor markers,intrahepatic bile duct dilatation,portal vein invasion,pathological differentiation,pathological type,vascular invasion,T stage,N stage and maximum tumor diameter were independent factors influencing the surgical procedure(all <0.05). Intrahepatic bile duct dilatation,pathological differentiation and T stage were independent prognostic factors for patients with intrahepatic cholangiocarcinoma(all <0.05). Intrahepatic bile duct dilatation,differentiation and T stage were included as covariates in the mediation effect model. The results showed that the number of positive serum tumor markers before surgery had a negative predictive effect on the survival time of patients with intrahepatic cholangiocarcinoma (=-0.092, =0.039),and had a positive predictive effect on the surgical method (=0.244,<0.01). The number of positive serum tumor markers had a negative predictive effect on the survival time of patients with intrahepatic cholangiocarcinoma (=-0.151, =0.002). Direct and indirect effects accounted for 71.3% and 28.7% of total effects,respectively. The higher the positive number of preoperative tumor markers,the worse the prognosis of patients with intrahepatic cholangiocarcinoma. The number of positive cells not only directly affects the prognosis of patients,but also indirectly affects the prognosis of patients by affecting the surgical method.
探讨术前血清学肿瘤标志物阳性数量对肝内胆管癌患者手术方式及预后的影响。这是一项回顾性病例系列研究。回顾性收集了2010年10月至2019年4月在中国10家医院接受根治性切除的548例肝内胆管癌患者的数据。其中男性277例,女性271例,年龄为(57.8±10.2)岁(范围:23至84岁)。426例患者(77.7%)术前血清肿瘤标志物至少一项呈阳性。数据收集包括4项术前血清学肿瘤标志物结果、其他术前指标(5项前驱症状、6项病史、8项术前血清学指标、5项术前影像学指标和14项术前病理检查指标)、基线数据(性别和年龄)、手术方式及预后随访数据。将4项术前血清学肿瘤标志物结果及手术方式转化为分类变量。将术前血清肿瘤标志物阳性数量作为处理变量,手术方式作为中介变量,生存时间作为结局变量。采用单因素和多因素分析筛选出其他术前指标作为影响手术方式及患者预后的独立因素作为协变量来分析中介效应。纳入研究的548例患者中,176例(32.1%)接受了肝部分切除术,151例(27.5%)接受了半肝切除术,221例(40.3%)接受了肝部分切除术或半肝切除术联合其他治疗。单因素和多因素分析结果显示,血清肿瘤标志物阳性数量、肝内胆管扩张、门静脉侵犯、病理分化、病理类型、血管侵犯、T分期,N分期及最大肿瘤直径是影响手术方式的独立因素(均<0.05)。肝内胆管扩张、病理分化及T分期是肝内胆管癌患者的独立预后因素(均<0.05)。将肝内胆管扩张、分化及T分期纳入中介效应模型作为协变量。结果显示,术前血清肿瘤标志物阳性数量对肝内胆管癌患者生存时间有负向预测作用(=-0.092, =0.039),对手术方式有正向预测作用(=0.244,<0.01)。术前血清肿瘤标志物阳性数量对肝内胆管癌患者生存时间有负向预测作用(=-0.151, =0.002)。直接效应和间接效应分别占总效应的71.3%和28.7%。术前肿瘤标志物阳性数量越高,肝内胆管癌患者预后越差。阳性指标数量不仅直接影响患者预后,还通过影响手术方式间接影响患者预后。